These studies revealed that lactoferrin supplementation to enteral feeds with or without probiotics could significantly decrease the incidence of late-onset sepsis, NEC stage II or III, risk of hospital-acquired infection, and infection-related mortality in preterm infants without obvious adverse effects (Pammi and Suresh, 2017; He et al., 2018). This evidence concerns the gene LTF and infection.